A cross-sectional study conducted at MedUni Vienna including patients with chronic systolic heart failure has demonstrated great variations in patients' individual therapy response to ACE inhibitors, the first-line therapy for heart failure. It seems possible that the clinical picture is composed of various subgroups characterized by the over-activation of different endogenous systems. The results provide an explanatory approach to the question, why not all patients benefit equally from ACE inhibitors. The study supports ongoing efforts to develop a targeted, individualised therapy for heart failure patients (precision medicine).
Health systems should warn high risk patients by smartphone when cold weather is predicted
New research published in Experimental Physiology has suggested a 6-week CrossFit™ exercise programme can lead to improved control of blood sugar levels and decreased risk of heart disease in people with Type 2 diabetes.
A new scientific advisory reaffirms the American Heart Association’s recommendation to eat fish- especially those rich in Omega-3 fatty acids twice a week to help reduce the risk of heart failure, coronary heart disease, cardiac arrest and ischaemic stroke. The advisory is published in the American Heart Association’s journal Circulation.
The level of diversity of the ‘good bacteria’ in our digestive systems has been found to be linked to hardening of the arteries – in new research by experts at the University of Nottingham and King’s College London.
Annual well woman exams by OB/GYNs provide a golden opportunity to evaluate a woman’s heart health, according to a new joint advisory from the American Heart Association and the American College of Obstetricians and Gynecologists (ACOG) which stresses the benefits of collaborative care between OB/GYN specialists and cardiologists.